US8497385, 19B.2

ID: ALA3674586

Chembl Id: CHEMBL3674586

PubChem CID: 16090914

Max Phase: Preclinical

Molecular Formula: C48H74O15

Molecular Weight: 891.10

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H](CO)OC(=O)C[C@H](O)CCO[C@H](c3ccc(CCCOCCOCC)cc3)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3

Standard InChI:  InChI=1S/C48H74O15/c1-6-8-9-10-11-14-42(51)62-46-36(29-43(52)55-5)28-39-31-40(33-49)60-44(53)30-37(50)20-24-58-41(35-17-15-34(16-18-35)13-12-23-57-27-26-56-7-2)32-38-21-25-59-45(61-38)19-22-47(3,4)48(46,54)63-39/h15-19,22,29,37-41,45-46,49-50,54H,6-14,20-21,23-28,30-33H2,1-5H3/b22-19+,36-29+/t37-,38+,39+,40-,41+,45+,46+,48-/m1/s1

Standard InChI Key:  YCHHXTOJCHUHFE-PWYHEOJDSA-N

Associated Targets(non-human)

Prkca Protein kinase C alpha (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 891.10Molecular Weight (Monoisotopic): 890.5028AlogP: 6.13#Rotatable Bonds: 18
Polar Surface Area: 194.97Molecular Species: NEUTRALHBA: 15HBD: 3
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.64CX Basic pKa: CX LogP: 6.10CX LogD: 6.10
Aromatic Rings: 1Heavy Atoms: 63QED Weighted: 0.05Np Likeness Score: 1.06

References

1.  (2013)  Bryostatin analogues, synthetic methods and uses, 

Source

Source(1):